The Clinical Trials Office (CTO) provides administrative, research and educational services to the CancerInstitute investigators and research staff conducting clinical trials. It serves as the main coordinating centerfor cancer-related clinical trials from concept development and submission to closure including protocoldevelopment, regulatory and compliance guidance, administrative submissions, data collection and datamanagement, data analysis, and quality control functions, and serves as the administrative interface to otherclinical research organizations at the NYU Medical Center. The goals of this resource are to:Facilitate clinical trials by providing a framework for development, submission, and conduct of dinicaltrials.Enhance and facilitate data collection and reporting of clinical cancer research data.Provide educational programs for the CTO staff and clinical investigators.Promote interdisciplinary collaboration and a venue for translating research findings to the clinical arenaIn response to the previous critique, internal audits, and the review of external consultants, significantchanges have occurred within the CTO since the last review. These changes include the appointment ofnew medical and administrative directors, new standard operating procedures, and restructuring of datamanagement. These improvements have produced a CTO that better meets the needs of investigatorsperforms more effectively within the NYU School of Medicine clinical research environment. Currently, theCTO supervises 49 research staff and manages 158 open protocols. The CTO continues to expand andimprove its function to serve as the central coordinating center for the clinical research enterprise at theNYUCI.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016087-28
Application #
7714242
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-04-18
Project End
2013-02-28
Budget Start
2008-04-18
Budget End
2009-02-28
Support Year
28
Fiscal Year
2008
Total Cost
$102,845
Indirect Cost
Name
New York University
Department
Type
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Snetkova, Valentina; Skok, Jane A (2018) Enhancer talk. Epigenomics 10:483-498
Litwinoff, Evelyn M S; Gold, Merav Y; Singh, Karan et al. (2018) Myeloid ATG16L1 does not affect adipose tissue inflammation or body mass in mice fed high fat diet. Obes Res Clin Pract 12:174-186
Lee, Chul-Hwan; Holder, Marlene; Grau, Daniel et al. (2018) Distinct Stimulatory Mechanisms Regulate the Catalytic Activity of Polycomb Repressive Complex 2. Mol Cell 70:435-448.e5
Fan, Xiaozhou; Alekseyenko, Alexander V; Wu, Jing et al. (2018) Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study. Gut 67:120-127
Gregory, Ann C; Sullivan, Matthew B; Segal, Leopoldo N et al. (2018) Smoking is associated with quantifiable differences in the human lung DNA virome and metabolome. Respir Res 19:174
Taylor, Martin S; Altukhov, Ilya; Molloy, Kelly R et al. (2018) Dissection of affinity captured LINE-1 macromolecular complexes. Elife 7:
Bertrand, Anne; Baron, Maria; Hoang, Dung M et al. (2018) In Vivo Evaluation of Neuronal Transport in Murine Models of Neurodegeneration Using Manganese-Enhanced MRI. Methods Mol Biol 1779:527-541
Jung, Seungyoun; Allen, Naomi; Arslan, Alan A et al. (2018) Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts. Int J Cancer 142:262-270
Wang, Sophia S; Carrington, Mary; Berndt, Sonja I et al. (2018) HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res 78:4086-4096
Kirkling, Margaret E; Cytlak, Urszula; Lau, Colleen M et al. (2018) Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells. Cell Rep 23:3658-3672.e6

Showing the most recent 10 out of 1170 publications